Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
+15.82%
adds when stocks drop
when a holding falls −10%+
Middle response
-7.73%
baseline attrition
Rally response
+1.00%
adds into rallies
when a holding rises +10%+
Top positions · 10
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| — | $294M | 40.8% | — | 2.5 yr |
| DYNDyne Therapeutics, Inc. | $84M | 11.7% | +73.3% | 2.5 yr |
| VORVor Biopharma Inc. | $73M | 10.2% | +24.3% | 0.8 yr |
| — | $66M | 9.1% | — | 2.5 yr |
| MPLTMapLight Therapeutics, I | $66M | 9.1% | — | 0.5 yr |
| DMRAGalecto, Inc. | $63M | 8.8% | — | 0.3 yr |
| — | $31M | 4.3% | — | 0.5 yr |
| REPLReplimune Group, Inc. | $21M | 3.0% | -21.5% | 2.5 yr |
| BCYCBicycle Therapeutics plc | $16M | 2.2% | -45.3% | 2.0 yr |
| ENGNWenGene Holdings Inc. War | $7M | 1.0% | — | 2.5 yr |
Portfolio composition (YoY)
Industry mix
Unknown54.1%-10.4pp$391M
Biotechnology45.9%+10.4pp$331M
Country
Unknown54.1%-10.4pp
US42.6%+14.7pp
GB2.2%-4.9pp
CA1.0%+0.6pp
Top 5: 80.8% · Top 10: 100.0% · Top 25: 100.0%
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $722M | 10 | +25.87% | +17.59% | +8.28% | -0.05B |
| 2025-12-31 | $763M | 10 | -31.08% | +17.72% | -48.79% | +0.09B |
| 2025-09-30 | $500M | 9 | -62.76% | +17.52% | -80.28% | +0.12B |
| 2025-06-30 | $369M | 8 | -61.72% | +14.94% | -76.67% | -0.00B |
| 2025-03-31 | $414M | 7 | -49.73% | +8.30% | -58.03% | +0.08B |
| 2024-12-31 | $592M | 8 | +57.73% | +24.89% | +32.85% | +0.17B |
| 2024-09-30 | $582M | 7 | +5.38% | +5.75% | -0.37% | -0.13B |
| 2024-06-30 | $678M | 7 | +18.42% | +4.38% | +14.04% | -0.16B |
| 2024-03-31 | $707M | 6 | +74.45% | +10.39% | +64.06% | +0.12B |
| 2023-12-31 | $339M | 6 | — | — | — | — |